Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool

May 29, 2024

https://www.globenewswire.com/news-release/2024/05/29/2890236/0/en/Power-of-Recursion-OS-on-Display-at-Genome-Scale-in-Nature-Genetics-Paper-Detailing-Potential-Limitation-of-CRISPR-Gene-Editing-Tool.html

SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature Genetics scientific findings that highlights a potential limitation of CRISPR-Cas9 in gene editing – a key component in understanding disease mechanisms, and developing new therapeutic approaches.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.